iRhythm Technologies, Inc. (IRTC) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
iRhythm Technologies stock has doubled this year.
iRhythm Technologies, Inc. ( IRTC ) Q3 2025 Earnings Call October 30, 2025 4:30 PM EDT Company Participants Stephanie Zhadkevich - Director of Investor Relations Quentin Blackford - President, CEO & Director Daniel Wilson - CFO & Principal Financial Officer Conference Call Participants Nathan Treybeck - Wells Fargo Securities, LLC, Research Division Richard Newitter - Truist Securities, Inc., Research Division David Saxon - Needham & Company, LLC, Research Division Sam Eiber - BTIG, LLC, Research Division Suraj Kalia - Oppenheimer & Co. Inc., Research Division David Rescott - Robert W. Baird & Co. Incorporated, Research Division Stephanie Piazzola - BofA Securities, Research Division Max Kruszeski - William Blair & Company L.L.C.
iRhythm Technologies (IRTC) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to a loss of $1.26 per share a year ago.
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q2 2025 Earnings Conference Call July 31, 2025 4:30 PM ET Company Participants Daniel G. Wilson - CFO & Principal Financial Officer Quentin S.
iRhythm Technologies (IRTC) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to a loss of $0.61 per share a year ago.
iRhythm Technologies (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, IR Quentin Blackford - President & CEO Daniel Wilson - CFO Conference Call Participants Allen Gong - JPMorgan Kallum Titchmarsh - Morgan Stanley Macauley Kilbane - William Blair Nathan Treybeck - Wells Fargo David Rescott - Baird David Saxon - Needham & Company Suraj Kalia - Oppenheimer Jon Young - Canaccord Genuity Sam Eiber - BTIG Richard Newitter - Truist Operator Good afternoon. Thank you for attending the iRhythm Technologies, Inc. First Quarter 2025 Earnings Conference Call.
IRhythm Technologies (IRTC) came out with a quarterly loss of $0.95 per share versus the Zacks Consensus Estimate of a loss of $0.89. This compares to loss of $1.47 per share a year ago.
iRhythm Technologies (IRTC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, IR Quentin Blackford - President & CEO Daniel Wilson - CFO Conference Call Participants Macauley Kilbane - William Blair Lilia-Celine Lozada - JPMorgan Kallum Titchmarsh - Morgan Stanley Nathan Treybeck - Wells Fargo David Roman - Goldman Sachs Sam Eiber - BTIG Jon Young - Canaccord Genuity David Rescott - Baird Suraj Kalia - Oppenheimer Felipe Lamar - Truist Paige Chamberlain - Wolfe Research Operator Good afternoon. Thank you for attending today's iRhythm Technologies Q4 2024 Earnings Conference Call.
IRhythm Technologies (IRTC) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.30 per share. This compares to loss of $1.26 per share a year ago.